Business Context and Reporting Period
Company: Henry Schein, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 27, 2010
Business Overview: Henry Schein is a leading distributor of healthcare products and services to office-based practitioners, including dental, medical, and animal health professionals. The company operates through two reportable segments: Healthcare Distribution and Technology.
Key Financial Metrics
| Metric (in thousands) | Q1 2010 | Q1 2009 |
|---|---|---|
| Net Sales | $1,760,310 | $1,485,388 |
| Gross Profit | $513,033 | $438,363 |
| Gross Margin | 29.1% | 29.5% |
| Operating Income | $103,759 | $90,588 |
| Net Income (Total) | $67,252 | $59,300 |
| Net Income Attributable to Henry Schein | $60,900 | $54,851 |
| Diluted EPS | $0.66 | $0.61 |
| Cash from Operating Activities | $21,675 | $(27,128) |
| Cash and Cash Equivalents (End of Period) | $355,388 | $308,156 |
| Total Debt | $548,521 | $267,865 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 18.5% year-over-year. This was driven by a 14.6% increase in local currency (3.2% organic, 11.4% from acquisitions) and a 3.9% favorable foreign currency impact.
- Animal Health Segment: Sales in this segment surged 271.5% to $206.6 million, primarily due to the acquisition of a majority interest in Butler Animal Health Supply, LLC (BAHS).
- Restructuring Costs: Restructuring expenses increased significantly to $12.3 million from $4.0 million in the prior year, reflecting headcount reductions of 184 positions and facility closures.
- Debt Levels: Total debt more than doubled to $548.5 million from $267.9 million, largely due to $320.0 million in debt incurred by the BAHS subsidiary to finance the acquisition.
- Operating Cash Flow: Improved from a use of $27.1 million in Q1 2009 to a provision of $21.7 million in Q1 2010, attributed to favorable working capital changes and higher net income.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects to invest approximately $35 million to $45 million for the remainder of the fiscal year in capital projects to modernize facilities and integrate operations.
- Regulatory Risks: The Patient Protection and Affordable Care Act (Health Care Reform Bill) imposes new reporting requirements and a potential 2.3% excise tax on medical device sales starting in 2013. The company notes uncertainty regarding whether it will be classified as a "manufacturer" subject to these rules.
- Acquisition Integration: The company is integrating the BAHS acquisition, which involves separate information systems. This represents a material change in internal controls over financial reporting.
- Liquidity: The company maintains a $400 million revolving credit facility with no outstanding borrowings as of March 27, 2010. Management believes current cash and credit facilities are sufficient for foreseeable needs.
- Investment Liquidity: Approximately $19.8 million is invested in auction-rate securities (ARS) which have failed to settle since 2008. While rated AAA, these cannot be liquidated in the near term, though the company does not expect this to impact operations.
Investor Verification Checklist
- BAHS Integration: Verify the progress of integrating Butler Animal Health Supply's systems and the realization of anticipated synergies.
- Debt Servicing: Monitor the ability of the BAHS subsidiary to service its $320 million debt load, which includes prepayment provisions based on excess cash flows.
- Regulatory Compliance: Track the issuance of regulations under the Health Care Reform Bill to determine if Henry Schein is subject to new reporting or tax obligations.
- ARS Exposure: Review the status of the $19.8 million auction-rate securities portfolio for any changes in credit quality or redemption opportunities.
- Restructuring Completion: Confirm the timeline for the completion of the $12.3 million restructuring plan and the associated cost savings.